Literature DB >> 11448458

6-hydroxydopamine-induced nuclear factor-kappa B activation in PC12 cells.

D Blum1, S Torch, M F Nissou, J M Verna.   

Abstract

The involvement of nuclear Factor-kappa B (NF-kappa B) transcription factor in PC12 cell death triggered by the dopaminergic neurotoxin 6-hydroxydopamine (6-OHDA) was investigated. Results show that oxidative stress generated by 6-OHDA activates NF-kappa B. When the NF-kappa B activation was inhibited by parthenolide, PC12 cell death induced by 6-OHDA was significantly increased, thus suggesting an involvement of this transcription factor in a protective mechanism against 6-OHDA toxicity. To further assess this hypothesis, we studied the involvement of NF-kappa B in the protective effect of two anti-apoptotic genes, bcl-2 and bfl-1. Although Bcl-2 and Bfl-1 expression normally protects PC12 cells from 6-OHDA, parthenolide strongly decreased the beneficial effects afforded by transgene expression. These results suggest: (1) that the transcription factor NF-kappa B is likely associated with the protection of catecholaminergic PC12 cells and (2) that the protective effects afforded by bcl-2 and bfl-1 expression may be dependent on NF-kappa activation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11448458     DOI: 10.1016/s0006-2952(01)00680-3

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  10 in total

1.  Annexin A1: a central player in the anti-inflammatory and neuroprotective role of microglia.

Authors:  Simon McArthur; Enrico Cristante; Mario Paterno; Helen Christian; Federico Roncaroli; Glenda E Gillies; Egle Solito
Journal:  J Immunol       Date:  2010-10-20       Impact factor: 5.422

2.  Stabilization of Nrf2 by tBHQ prevents LPS-induced apoptosis in differentiated PC12 cells.

Authors:  Fariba Khodagholi; Solaleh Khoramian Tusi
Journal:  Mol Cell Biochem       Date:  2011-04-02       Impact factor: 3.396

3.  Coenzyme Q(10) provides neuroprotection in iron-induced apoptosis in dopaminergic neurons.

Authors:  Patcharee Kooncumchoo; Sushil Sharma; James Porter; Piyarat Govitrapong; Manuchir Ebadi
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

4.  The role of NF-kappaB in 6-hydroxydopamine- and TNFalpha-induced apoptosis of PC12 cells.

Authors:  Victoria Tarabin; Markus Schwaninger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-05-13       Impact factor: 3.000

5.  Antioxidant and Anti-Apoptotic Activity of Octadecaneuropeptide Against 6-OHDA Toxicity in Cultured Rat Astrocytes.

Authors:  Hadhemi Kaddour; Yosra Hamdi; Fatma Amri; Seyma Bahdoudi; Ibtissem Bouannee; Jérôme Leprince; Sami Zekri; Hubert Vaudry; Marie-Christine Tonon; David Vaudry; Mohamed Amri; Sana Mezghani; Olfa Masmoudi-Kouki
Journal:  J Mol Neurosci       Date:  2018-10-20       Impact factor: 3.444

6.  Targeting the progression of Parkinson's disease.

Authors:  J L George; S Mok; D Moses; S Wilkins; A I Bush; R A Cherny; D I Finkelstein
Journal:  Curr Neuropharmacol       Date:  2009-03       Impact factor: 7.363

7.  Endogenous repair by the activation of cell survival signalling cascades during the early stages of rat Parkinsonism.

Authors:  Nga-Ping Lui; Liang-Wei Chen; Wing-Ho Yung; Ying-Shing Chan; Ken Kin-Lam Yung
Journal:  PLoS One       Date:  2012-12-12       Impact factor: 3.240

8.  Wnt1 Promotes EAAT2 Expression and Mediates the Protective Effects of Astrocytes on Dopaminergic Cells in Parkinson's Disease.

Authors:  Lei Wei; Chuan Chen; Li Ding; Mingshu Mo; Jing Zou; Zhenze Lu; Haiyan Li; Haotian Wu; Yongqiang Dai; Pingyi Xu; Zhengqi Lu
Journal:  Neural Plast       Date:  2019-09-09       Impact factor: 3.599

Review 9.  New Insights into the Role of Cysteine Cathepsins in Neuroinflammation.

Authors:  Anja Pišlar; Lara Bolčina; Janko Kos
Journal:  Biomolecules       Date:  2021-11-30

Review 10.  Lysosomal peptidases-intriguing roles in cancer progression and neurodegeneration.

Authors:  Janko Kos; Ana Mitrović; Milica Perišić Nanut; Anja Pišlar
Journal:  FEBS Open Bio       Date:  2022-02-03       Impact factor: 2.693

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.